or Try an Advanced Search...

    Percutaneous Coronary Intervention Stocks List

    Symbol Grade Name % Change
    NSPR D InspireMD, Inc. -2.05
    LLY A Eli Lilly and Company 1.83
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Percutaneous Coronary Intervention stocks.

    Symbol Grade Name Weight
    IHE B iShares U.S. Pharmaceutical ETF 23.55
    OZEM B Roundhill GLP-1 & Weight Loss ETF 21.39
    MEDX B Horizon Kinetics Medical ETF 16.22
    THNR B Amplify Weight Loss Drug & Treatment ETF 15.58
    IYH B iShares U.S. Healthcare ETF 13.74
    View all Percutaneous Coronary Intervention ETFs...
    Compare ETFs
    Compare IHE to IYH Compare IHE to MEDX Compare MEDX to IYH

        Percutaneous Coronary Intervention Stocks Recent News

        Date Stock Title
        Jul 5 LLY Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
        Jul 5 LLY Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
        Jul 5 LLY Eli Lilly Remains an Equities Outlier
        Jul 5 LLY Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
        Jul 4 LLY Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
        Jul 4 LLY NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
        Jul 4 LLY Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
        Jul 4 LLY FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
        Jul 4 LLY Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
        Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
        Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
        Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
        Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
        Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
        Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
        Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
        Jul 3 LLY Top 3 Health Care Stocks That May Crash This Quarter
        Jul 3 LLY Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
        Jul 3 LLY 5 Things to Know Before the Stock Market Opens
        Jul 3 LLY Eli Lilly Advances Alzheimer's Solutions With Kisunla Approval
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes
        Percutaneous Coronary Intervention

        Percutaneous Coronary Intervention (PCI) is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. It involves inserting a catheter into a blood vessel in the arm or leg and guiding it to the narrowed or blocked coronary artery. A balloon is then inflated to widen the artery and a stent is inserted to keep it open. PCI can improve blood flow to the heart and reduce the risk of a heart attack.

        Browse All Tags